Medical use of cannabis for Alzheimer’s
By Dr. Girivar Singhal
Alzheimer’s disease (AD) is an illness of the brain. The brain is the common site of amyloid deposition, although it is not directly affected in form of acquired systematic amyloidosis. Intracerebral and cerebrovascular amyloid deposits are seen in Alzheimer’s disease. Amyloid deposits are frequently found in the elderly, particularly cerebral deposits of A4 protein. Age is the main risk factor for Alzheimer’s disease as incidence increases exponentially with the age. Head trauma and vascular risk factors also increase Alzheimer’s disease risk. Epidemiological studied show that taking anti-inflammatory over a long period may confer some protection.
Cannabinoids, the active chemical components of marijuana, can regulate inflammation in the brain and promote neurogenesis — the growth of new neural pathways — even in cells damaged by age or trauma. As more research has indicated that brain inflammation appears to be a cause of several degenerative diseases, marijuana has been getting a closer look as a potential preventive medication. THC, the chemical compound responsible for marijuana’s high, “could be considerably better at suppressing the abnormal clumping of malformed proteins that is a hallmark of Alzheimer’s disease than any currently approved prescription.” The research team predicted that cannabinoid-based medications “will be the new breakout medicine treatments of the near future.”
Dr. Girivar Singhal for the Marijuana Company
Before using Marijuana for medical purposes, consult with a physician.